Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableLooking for participantsNCT06024837What this trial is testingPerformance of Spectral CT-scan in Patients With Metastatic Colorectal Cancer: a Prospective Multicentre StudyWho this might be right forColo-rectal Cancer Centre Hospitalier Universitaire de Saint Etienne 100
Early research (Phase 1)Study completedNCT00003867What this trial is testingIrinotecan and Capecitabine in Treating Patients With Solid TumorsWho this might be right forCancer Montefiore Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Large-scale testing (Phase 3)Ended earlyNCT00023868What this trial is testingCombination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)Who this might be right forColorectal CancerMetastatic Cancer American College of Radiology Imaging Network
Testing effectiveness (Phase 2)WithdrawnNCT00408772What this trial is testingOxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer University of California, Davis
Testing effectiveness (Phase 2)Study completedNCT00019760What this trial is testingIsolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverWho this might be right forRecurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00003753What this trial is testingFloxuridine, Dexamethasone, and Irinotecan After Surgery in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT07410676What this trial is testingEBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsWho this might be right forCancerSarcomaLeukaemia+12 more Essen Biotech 83
Early research (Phase 1)Study completedNCT00005616What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00003834What this trial is testingCombination Chemotherapy in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Alliance for Clinical Trials in Oncology 44
Testing effectiveness (Phase 2)UnknownNCT00513266What this trial is testingCombination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by SurgeryWho this might be right forColorectal CancerMetastatic Cancer Centre Hospitalier Universitaire Vaudois 35
Testing effectiveness (Phase 2)Study completedNCT00056030What this trial is testingCombination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Alliance for Clinical Trials in Oncology 73
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Large-scale testing (Phase 3)Ended earlyNCT00268463What this trial is testingOxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer NSABP Foundation Inc 22
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Testing effectiveness (Phase 2)Study completedNCT00103298What this trial is testingIsolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00103142What this trial is testingVaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer Michael Morse, MD 74
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24